AMENDED DEVELOPMENT AND LICENSE AGREEMENT By and between ALMIRALL, S.A. and ASLAN PHARMACEUTICALS PTE. LTD. Dated: December 21, 2015Development and License Agreement • December 20th, 2017 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations
This AMENDED DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated as of December 21, 2015 (“Effective Date”), is entered by and between ALMIRALL, S.A. (“ALMIRALL”), a Spanish corporation having its principal offices at Ronda de General Mitre, 151, 08022 Barcelona, Spain, and ASLAN PHARMACEUTICALS Pte. Ltd. (“ASLAN”), a Singapore corporation having its principal offices at 10A Bukit Pasoh Road, Singapore 089824. ALMIRALL and ASLAN shall be referred to individually as a “Party” and collectively as the “Parties”.
DATED THIS 10th DAY OF OCTOBER 2016 Between NANYANG TECHNOLOGICAL UNIVERSITY And ASLAN PHARMACEUTICALS PTE LTD LICENSING AND RESEARCH COLLABORATION AGREEMENTAnd Research Collaboration Agreement • December 20th, 2017 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations
